Uromedica Competitors and Similar CompaniesClear all

Uromedica's competitors and similar companies include Procept BioRobotics, TBS INDIA Telematic & Biomedical Services, Shockwave Medical and Outset Medical.

	Uromedica Uromedica is a company that develops implantable balloon therapy to treat male and female stress urinary incontinence.	Procept BioRobotics Procept BioRobotics is a surgical robotics company that provides urologic care solutions.	TBS INDIA Telematic & Biomedical Services TBS INDIA Telematic & Biomedical Services is a company that provides healthcare management technological solutions.	Shockwave Medical Shockwave Medical is a company developing interventional therapy for calcified cardiovascular disease.	Outset Medical Outset Medical (formerly known as HD+) is a medical technology company that develops hemodialysis systems.
Founding Date	Founding Date 1997	Founding Date 2009	Founding Date 2000	Founding Date 2009	Founding Date 2003
Type	Type Private	Type Public	Type Private	Type Public	Type Public
Tags	Tags Healthcare healthtech medical devices	Tags Healthcare medical devices robotics surgical solutions therapy	Tags Healthcare healthtech medical devices	Tags Healthcare healthtech medical devices	Tags Healthcare healthtech medical devices
Locations	Locations Minneapolis, US HQ	Locations San Jose, US HQ	Locations Bengaluru, IN HQ	Locations Santa Clara, US HQ Kleve, DE	Locations San Jose, US HQ
Employees	Employees 303% decrease	Employees 6682% increase	Employees 3891% increase	Employees 162	Employees 7171% decrease
Valuation ($)	Valuation ($) N/A	Valuation ($) 5 b	Valuation ($) N/A	Valuation ($) 12.6 b	Valuation ($) 28.8 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $308.1m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $730.2m (FY, 2023)	Revenue (est.) $119.5m (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods $111.8m (FY, 2025)	Cost of goods N/A	Cost of goods $95.4m (FY, 2023)	Cost of goods $72.7m (FY, 2025)
Gross profit	Gross profit N/A	Gross profit $196.2m (FY, 2025)	Gross profit N/A	Gross profit $634.8m (FY, 2023)	Gross profit $46.8m (FY, 2025)
Net income	Net income N/A	Net income ($95.6m) (FY, 2025)	Net income N/A	Net income $147.3m (FY, 2023)	Net income ($81.7m) (FY, 2025)
Funding
Total funding raised	Total funding raised $ 1.5m	Total funding raised $ 328m	Total funding raised N/A	Total funding raised $ 147.5m	Total funding raised $ 489.5m